Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 5/20 | 0.79 |
| ▸ | BLM | P54132 | 2/20 | 0.79 |
| ▸ | USP2 | O75604 | 1/20 | 0.79 |
| ▸ | TSHR | P16473 | 1/20 | 0.79 |
| ▸ | EDNRA | P25101 | 1/20 | 0.79 |
| ▸ | HTR2A | P28223 | 1/20 | 0.79 |
| ▸ | RECQL | P46063 | 1/20 | 0.79 |
| ▸ | HBB | P68871 | 1/20 | 0.79 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.79 |
| ▸ | TK1 | P04183 | 2/20 | 0.73 |
| ▸ | POLB | P06746 | 2/20 | 0.69 |
| ▸ | HPRT1 | P00492 | 9/20 | 0.66 |
| ▸ | POLA1 | P09884 | 1/20 | 0.66 |
| ▸ | POLG | P54098 | 1/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.61 |
| ▸ | VCP | P55072 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10430808 | 0.92 | PNP (0.71) | PNPBLMUSP2TSHREDNRA | |
| SCHEMBL11730981 | 0.89 | PNP (0.95) | PNPBLMUSP2TSHREDNRA | |
| Acyclovir SCHEMBL2269160 | 0.88 | PNP (1.00) | PNPBLMUSP2TSHREDNRA | |
| Acyclovir SCHEMBL3664893 | 0.88 | PNP (1.00) | PNPBLMUSP2TSHREDNRA | |
| Acyclovir SCHEMBL3175 | 0.88 | PNP (1.00) | PNPBLMUSP2TSHREDNRA | |
| SCHEMBL350397 | 0.88 | TK1 (0.82) | PNPBLMUSP2TSHREDNRA | |
| Acyclovir SCHEMBL572160 | 0.88 | PNP (0.93) | PNPBLMUSP2TSHREDNRA | |
| SCHEMBL214935 | 0.87 | POLB (0.65) | PNPBLMUSP2TSHREDNRA | |
| Acyclovir SCHEMBL16060281 | 0.87 | PNP (0.97) | PNPBLMUSP2TSHREDNRA | |
| Acyclovir SCHEMBL19031784 | 0.87 | PNP (0.97) | PNPBLMUSP2TSHREDNRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1444969-B1 | Absorbent article | KAO CORP (JP) | 2011-08-31 | — | — | EP | disclosed |
| US-20040158216-A1 | Absorbent article | KAO CORPORATION (JP) | 2004-08-12 | — | — | US | disclosed |
| EP-1444969-A1 | Absorbent article | Kao Corporation (JP) | 2004-08-11 | — | — | EP | disclosed |
| EP-0862570-A1 | PROCESS FOR THE PREPARATION OF 9- (2-HYDROXYETHOXY)METHYL]GUANINE | ARCHIMICA S.P.A. (IT) | 1998-09-09 | — | — | EP | disclosed |
| EP-0594677-A4 | ANTIVIRAL LIPONUCLEOSIDES: TREATMENT OF HEPATITIS B | VICAL INC (US) | 1997-09-17 | — | — | EP | disclosed |
| WO-1997018211-A1 | PROCESS FOR THE PREPARATION OF 9-[(2-HYDROXYETHOXY)METHYL]GUANINE | ARCHIMICA S.P.A. (IT) | 1997-05-22 | — | — | WO | disclosed |
| EP-0602118-A4 | -i(IN VIVO) GENE TRANSFER USING IMPLANTED RETROVIRAL PRODUCER CELLS. | UNIV CALIFORNIA (US) | 1996-02-28 | — | — | EP | disclosed |
| EP-0602118-A1 | $i(IN VIVO) GENE TRANSFER USING IMPLANTED RETROVIRAL PRODUCER CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1994-06-22 | — | — | EP | disclosed |
| EP-0594677-A1 | ANTIVIRAL LIPONUCLEOSIDES: TREATMENT OF HEPATITIS B | NeXstar Pharmaceuticals, Inc. (US) | 1994-05-04 | — | — | EP | disclosed |
| EP-0564645-A1 | TRANSFORMANT CELLS FOR THE PROPHYLAXIS OR TREATMENT OF DISEASES CAUSED BY VIRUSES, PARTICULARLY PATHOGENIC RETROVIRUSES | UNIVERSITE PIERRE ET MARIE CURIE PARIS VI (FR) | 1993-10-13 | — | — | EP | disclosed |
| WO-1993004167-A1 | IN VIVO GENE TRANSFER USING IMPLANTED RETROVIRAL PRODUCER CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1993-03-04 | — | — | WO | disclosed |
| WO-1993000910-A1 | ANTIVIRAL LIPONUCLEOSIDES: TREATMENT OF HEPATITIS B | VICAL, INC. (US) | 1993-01-21 | — | — | WO | disclosed |